Dr. Rajeev Shukla, MD

Dr. Shukla practices at Rajeev Shukla MD Inc in Lodi, California.

Dr. Shukla's NPI, 1548289630, was assigned on July 19, 2006. Dr. Shukla graduated from University of Toronto Faculty of Medicine in 1991. Dr. Shukla holds California license A51690.

Dr. Shukla's primary practice is Rajeev Shukla MD Inc, at 845 S Fairmont Ave, Lodi, CA 95240 in San Joaquin County. The practice phone is (209) 242-5385.

Dr. Shukla's primary practice is Rajeev Shukla MD Inc in Lodi, California. Dr. Shukla is also affiliated with Adventist Health Lodi Memorial. Dmand AI also links Dr. Shukla to 4 more hospitals, 3 home health agencies and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shukla practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Shukla's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Shukla is board certified in internal medicine by the American Board of Internal Medicine. Dr. Shukla is licensed in California.

Dmand AI lists acid reflux, acute gastroduodenitis, acute sinusitis, acute skin infection, aneurysm, ankle or foot injury, arteritis and arthritis among the conditions Dr. Shukla treats.

CMS data shows 3,884 Medicare services from Dr. Shukla across 20 procedure codes in 2024, for 526 Medicare patients. Medicare paid $200,722 for them. Every service was in an office.

CMS counts 526 Medicare patients who saw Dr. Shukla in 2024. The largest group is 75 to 84, with 233 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shukla's median patient age at 75, with 49% women.

In 2024, Dr. Shukla wrote 11,795 Medicare Part D claims for 745 patients. 88% of them were for generic drugs. CMS names the drug for 11,027 of them, across 145 drugs with 11 or more claims each, at $1,227,056 in total drug cost. In 2023, CMS named 11,117 claims across 143 drugs.

Dr. Shukla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shukla as offering telehealth. CMS counts 52 procedures of removal of skin lesions by Dr. Shukla, more than 72% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 41 papers to Dr. Shukla, published from 2010 to 2025. 2019 was the busiest year, with 5. The most frequent topics are Cell Line, Tumor, Rhabdomyosarcoma, Alveolar and Tomography, X-Ray Computed. Dr. Shukla has published most often in J Pediatr Surg. Dr. Shukla's most frequent co-authors are Prajnan Das, MD, MPH, Abraham Ari Hakimi, MD and Madiha Iqbal, MBBS.

CMS Open Payments shows 1,255 general payments to Dr. Shukla from 56 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $3,102.

Dr. Shukla graduated from University of Toronto Faculty of Medicine in 1991.

Dr. Shukla is in network with 9 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.